13F HOLDINGS REPORT
Artal Group S.A.
Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0001053906-25-000012
Total Value
$758.2M
Positions
2
Other Managers
5
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 9,507,990 | $574.4M | 75.75% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $183.8M | 24.25% |